References
Hamai Y, Hihara J, Emi M, et al. Evaluation of prognostic factors for esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy followed by surgery. World J Surg. 2018;42:1496–1505.
Hamai Y, Emi M, Ibuki Y, et al. Early recurrence and cancer death after trimodal therapy for esophageal squamous cell carcinoma. Anticancer Res. 2019;39:1433–1440.
Hamai Y, Hihara J, Emi M, et al. Clinical significance of 18F-Fluorodeoxyglucose-positron emission tomography-positive lymph nodes to outcomes of trimodal therapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:1869–1878.
Kurokawa T, Hamai Y, Emi M, et al. Risk factors for recurrence in esophageal squamous cell carcinoma without pathological complete response after trimodal Therapy. Anticancer Res. 2020;40:4387–4394.
Hamai Y, Emi M, Ibuki Y, et al. Distribution of lymph node metastasis in esophageal squamous cell carcinoma after trimodal therapy. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09106-0.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Yoichi Hamai has no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hamai, Y. ASO Author Reflections: Lymph Node Metastasis of Esophageal Cancer After Trimodal Therapy. Ann Surg Oncol 28, 1808–1809 (2021). https://doi.org/10.1245/s10434-020-09121-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09121-1